Sun Pharma’s New LED BLU-U Device for AK Scores U.S. FDA Nod
The U.S. Food and Drug Administration (FDA) has approved the next generation of Sun Pharma’s BLU-U Blue Light Photodynamic Therapy (PDT) Illuminator for treating actinic keratoses (AK). The approval was granted under FDA’s Real-Time Review Program, which streamlines the review of applications for new drugs and biologics, particularly for oncology drugs, by allowing the FDA to […]